Concurrent ADT, Radiotherapy Yields Better Outcomes in Prostate Cancer

Concurrent/adjuvant short-term androgen deprivation therapy (ADT) with prostate-only radiation therapy for localized prostate cancer may improve outcomes. In a pooled analysis of 12 trials, concurrent/adjuvant vs. neoadjuvant/concurrent ADT improved metastasis-free and overall survival.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ